Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma

Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma

<p><strong>Purpose</strong><br/> Our purpose was to describe the patterns and predictors of treatment failure in patients receiving definitive chemoradiation therapy (CRT) for anal squamous cell carcinoma (ASCC), delivered using intensity modulated radiation therapy (IMRT).&l...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Shakir, R, Adams, R, Cooper, R, Downing, A, Geh, I, Gilbert, D, Jacobs, C, Jones, C, Lorimer, C, Namelo, W, Sebag-Montefiore, D, Shaw, P, Muirhead, R
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Elsevier 2019

समान संसाधन

Toxicity, tolerability & compliance of concurrent capecitabine or 5-fluorouracil in the radical management of anal cancer with single-dose mitomycin-C and intensity modulated radiation therapy: evaluation of a national cohort
द्वारा: Jones, C, और अन्य
प्रकाशित: (2018)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
द्वारा: Robinson, M, और अन्य
प्रकाशित: (2019)

Stepwise multicenter introduction of intensity modulated radiation therapy for anal cancer in the United Kingdom: From consensus guidance to large-scale prospective audit, prior to future clinical trials
द्वारा: Gilbert, D, और अन्य
प्रकाशित: (2016)

Personalized dose escalation in anal cancer
द्वारा: Robinson, M, और अन्य
प्रकाशित: (2016)

Changes in pelvic active bone marrow seen on FDG-PET in patients receiving concurrent chemoradiation for anal cancer
द्वारा: Robinson, M, और अन्य
प्रकाशित: (2018)

A novel pretrial contouring exercise for the UK led PersonaLising Anal cancer radioTherapy dOse (PLATO) trial
द्वारा: Robinson, M, और अन्य
प्रकाशित: (2017)

Initial results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
द्वारा: Muirhead, R, और अन्य
प्रकाशित: (2016)

Is there a role for a biological boost in squamous cell anal cancer?
द्वारा: Sabbagh, A, और अन्य
प्रकाशित: (2018)

Oncologic outcomes of squamous cell carcinoma of the anal canal after chemoradiation therapy
द्वारा: Dae Ro Lim, और अन्य
प्रकाशित: (2016-06-01)

Treatment planning of dose escalation for anal cancer in the PLATO trial
द्वारा: Abbott, N, और अन्य
प्रकाशित: (2017)

Is there a role for an FDG derived biological boost in squamous cell anal cancer?
द्वारा: Sabbagh, A, और अन्य
प्रकाशित: (2018)

Early stage anal margin cancer: towards evidence‐based management
द्वारा: Renehan, A, और अन्य
प्रकाशित: (2019)

Is there a role for an 18F-fluorodeoxyglucose-derived biological boost in squamous cell anal cancer?
द्वारा: Sabbagh, A, और अन्य
प्रकाशित: (2018)

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
द्वारा: Dewas Claire, और अन्य
प्रकाशित: (2012-11-01)

Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review
द्वारा: Stelios Theophanous, और अन्य
प्रकाशित: (2022-06-01)

Proton beam therapy – the challenges of delivering high-quality evidence of clinical benefit
द्वारा: National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group, और अन्य
प्रकाशित: (2018)

Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer
द्वारा: Browning, RJ, और अन्य
प्रकाशित: (2021)

Tracheal-Mediastinal Fistula Post-chemoradiation Therapy
द्वारा: Joseph McCarthy, और अन्य
प्रकाशित: (2014-11-01)

Chemoradiation therapy for localized colorectal cancer: a view from the outside
द्वारा: F. Sh. Akhmetzyanov, और अन्य
प्रकाशित: (2023-01-01)

Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis
द्वारा: Alessandra Arcelli, और अन्य
प्रकाशित: (2019-02-01)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
द्वारा: Warren, S, और अन्य
प्रकाशित: (2014)

Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
द्वारा: MacGregor, T, और अन्य
प्रकाशित: (2012)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
द्वारा: Warren, S, और अन्य
प्रकाशित: (2017)

Optimising RT dose for anal cancer - the development of three clinical trials in one platform
द्वारा: Sebag-Montefiore, D, और अन्य
प्रकाशित: (2017)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
द्वारा: Kelsey L. Corrigan, MD, MPH, और अन्य
प्रकाशित: (2022-07-01)

Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study
द्वारा: William Chu, और अन्य
प्रकाशित: (2023-06-01)

Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities
द्वारा: Samuel Aguiar Junior, और अन्य
प्रकाशित: (2009-11-01)

Results of implementation of a program of individual support of chemoradiation therapy in patients with head and neck tumors
द्वारा: A. R. Gevorkov, और अन्य
प्रकाशित: (2021-01-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
द्वारा: Mukherjee, S, और अन्य
प्रकाशित: (2018)

Comparison of radiation therapy alone and concurrent chemoradiation therapy for in operable cervical cancer
द्वारा: Md. Zillur Rahman Bhuiyan, और अन्य
प्रकाशित: (2016-08-01)

A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer
द्वारा: Marissa B. Savoie, और अन्य
प्रकाशित: (2019-09-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
द्वारा: Mukherjee, S, और अन्य
प्रकाशित: (2017)

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
द्वारा: Honsoul Kim, और अन्य
प्रकाशित: (2016-01-01)

Non surgical therapy for chronic anal fissure
द्वारा: M. V. Abritsova, और अन्य
प्रकाशित: (2022-05-01)

Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
द्वारा: Brunner, T, और अन्य
प्रकाशित: (2008)

DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies
द्वारा: Mohammad Rezaee, और अन्य
प्रकाशित: (2012-01-01)

Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
प्रकाशित: (2009-12-01)

Effect of GSDMB polymorphism on sensitivity to chemoradiation therapy for cervical cancer
द्वारा: Ni Zhong, और अन्य
प्रकाशित: (2021-12-01)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
द्वारा: Casadei-Gardini A, और अन्य
प्रकाशित: (2019-04-01)

Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma
द्वारा: Fang He, और अन्य
प्रकाशित: (2024-12-01)